How AI, Innovation and Equity Are Reshaping Maternal Health

The Promise of AI in Maternal Healthcare

Artificial intelligence is rapidly finding its way into almost every industry, from finance to fitness. Healthcare is no exception. In maternal health specifically, AI holds extraordinary potential to improve outcomes, close long-standing gaps in care, and support mothers more effectively, if, and only if, it is integrated safely and grounded in evidence-based practice.

In recent years, we’ve seen a surge in AI-powered maternal health apps offering personalised guidance, early risk detection, and remote monitoring. When designed responsibly, this represents a meaningful step forward for preventative and personalised care.

Why Preventative Maternal Health Must Start Before Pregnancy

To truly deliver preventative maternal healthcare, we must engage women much earlier, ideally at the preconception stage. This is when we can begin collecting meaningful data on key biometrics, behaviours, and health patterns, building a complete picture of maternal health before pregnancy even begins.

Early engagement enables:

• Better risk identification

• More personalised care pathways

• Timely intervention before issues escalate

Prevention is not about replacing clinical care. It is about strengthening it with better insight, earlier action, and continuity.

Fragmentation: The Biggest Barrier to Better Maternal Outcomes

Throughout my nursing career and still today I have seen how fragmented maternal healthcare systems remain. Medical records rarely connect across services, and vital information is often scattered across multiple platforms.

This fragmentation:

• Increases the risk of missed warning signs

• Prevents longitudinal understanding of maternal health

• Undermines continuity from preconception through postpartum

Without connected data across the maternal journey, preventative care is impossible at scale.

How AI Can Enable Early Detection in Maternal Mental Health

So how might AI transform the early identification of conditions such as prenatal and postnatal depression?

AI is no longer confined to clinical settings. It is beginning to show real promise in detecting subtle changes in sleep, mood, stress, and recovery often long before symptoms escalate into diagnosable conditions.

Just as wearables like Oura track readiness and recovery, imagine a world where every mother receives personalised health insights and supportive prompts, tailored to her unique rhythm, before a health issue takes hold.

This is where AI becomes truly preventative.

Policy Momentum: Why the Timing Matters Now

The UK Women’s Health Strategy and the NHS Digital Transformation Plan both acknowledge the urgent need for digitised, preventative models of care to improve maternal outcomes and reduce long-term costs.

Despite the UK government spending over £1.5 billion annually on maternal mental health, outcomes remain inconsistent and in some areas, continue to worsen.

The truth is clear: Funding alone is not enough. Early detection requires a fundamental shift in approach. By integrating AI-powered insights at the preconception and early pregnancy stages, we can identify risk sooner, personalise interventions, and provide consistent, compassionate support throughout the maternal journey.

Building Continuity of Care with AI at Matresa

At Matresa, we believe continuity of care is the missing link. Mothers deserve connected, end-to-end support from preconception, through pregnancy, postpartum, and into the early years of their child’s life. By closing the gaps between fragmented systems and harnessing intelligent, evidence-based technology, Matresa is redefining what preventative and personalised maternal care can look like. Because when we care for the mother continuously, we strengthen the foundation for every family’s health.

The Market Opportunity in Digital Maternal Health

Alongside the growing clinical and emotional need lies a significant market opportunity:

• The global women’s digital health market is projected to grow from $2.59bn in 2023 to $9.53bn by 2030

• The broader maternal health market is expected to reach $28bn by 2029

• Maternal mental health alone is forecast to grow at a 28.5% CAGR

These figures reflect both the scale of unmet need and the demand for data-led, preventative solutions that genuinely improve outcomes.

NICE Opens the Door for Digital and AI Health Innovation

In October, the National Institute for Health and Care Excellence (NICE) expanded its evaluation framework to fast-track the approval of digital and AI health tools a pivotal shift for UK health innovation.

Why This Matters for Maternal Health

Historically, NHS adoption of digital tools has been slow and complex, even for evidence-based solutions. This new framework aims to streamline evaluation, accelerate adoption, and ensure validated technologies reach patients faster.

For innovators in maternal and women’s health, this opens the door to real collaboration. Solutions like Matresa built with GDPR-compliant data protection and measurable outcomes, could one day integrate seamlessly into NHS maternity pathways, bridging the gap between clinical and everyday maternal support.

Ethical AI and Equity in Maternal Healthcare

As AI becomes increasingly embedded in healthcare, it holds enormous potential to reduce inequality but only if it is designed with inclusion at its core.

Maternal outcomes remain starkly unequal, particularly for women from ethnic minority backgrounds, lower-income households, and rural communities. AI systems trained on biased or incomplete data risk reinforcing the very inequalities they aim to solve.

AI Can Support Equity When It Is Designed To:

• Analyse diverse, representative data sets

• Identify early risk in under-served populations

• Deliver insights across languages and levels of digital literacy

• Equip healthcare providers with richer, context-sensitive information

At Matresa, we believe AI in maternal health must be ethical, transparent, and evidence-led. Over time, our aim is to build a tailored model grounded in inclusive data, strong clinical guardrails, and safety-first design. Real innovation is not about faster algorithms, it’s about fairer outcomes and safer care.